Clinical trials
Phase 1/2 Lupus Erythematosus, Systemic trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 7 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Philadelphia | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Oklahoma Medical Research Foundation | 2 |
| AbelZeta Inc. | 1 |
| AstraZeneca | 1 |
| Boston Pharmaceuticals | 1 |
| Cabaletta Bio | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Daiichi Sankyo | 1 |
| DualityBio Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 26 |
| Lupus Nephritis | 8 |
| Arthritis, Rheumatoid | 4 |
| Autoimmune Diseases | 4 |
| Arthritis | 2 |
| Scleroderma, Systemic | 2 |
| Anemia, Hemolytic | 1 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
| Atherosclerosis | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.